Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04252066
A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
Sponsor: Amicus Therapeutics
View on ClinicalTrials.gov
Summary
This is a global prospective observational study of women with Fabry disease and their infants during pregnancy and/or breastfeeding. The study will evaluate outcomes of pregnancy and/or breastfeeding in women and infants exposed to migalastat.
Key Details
Gender
FEMALE
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2025-03-18
Completion Date
2030-02
Last Updated
2025-07-08
Healthy Volunteers
No
Conditions
Interventions
DRUG
migalastat
This is an observational study. Patients as described in Cohort 1 should have been exposed to at least 1 dose of migalastat during pregnancy and/or breastfeeding.
Locations (1)
Amicus Therapeutics, Inc. Pregnancy Registry
Philadelphia, Pennsylvania, United States